- €1.28bn
- €1.52bn
- €762.99m
- 94
- 34
- 85
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 535 | 556 | 574 | 684 | 763 |
Cost of Revenue | |||||
Gross Profit | 240 | 247 | 247 | 286 | 333 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 450 | 467 | 486 | 586 | 654 |
Operating Profit | 84.4 | 88.7 | 87.4 | 97.9 | 109 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 69.9 | 73.7 | 76.8 | 87.8 | 84.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 55.7 | 60 | 61.4 | 70.1 | 71 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 41.1 | 59.6 | 61 | 69.6 | 70.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 41.1 | 59.6 | 61 | 69.6 | 70.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.789 | 0.858 | 0.841 | 0.952 | 0.983 |
Dividends per Share |